Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk?

Affiliations

¹ Health Science Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil.
² Parasitic Biology Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil.
³ Tropical Medicine Graduate Program, Universidade Federal de Pernambuco, Recife, Brazil.
⁴ Department of Medicine, Universidade Federal de Sergipe, Aracaju, Brazil.
⁵ Department of Health Education, Universidade Federal de Sergipe, Lagarto, Brasil.
⁶ Department of Nursing, Universidade Federal de Sergipe, Lagarto, Brasil.
⁷ Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.
⁸ College of Pharmaceutical Sciences, Federal University of Vale do São Francisco (UNIVASF), Petrolina, Brazil.
⁹ Department of Medicine, Universidade Federal de Alagoas, Arapiraca, Brazil.
¹⁰ Department of Morphology, Universidade Federal de Sergipe, São Cristóvão, Brazil.
¹¹ Laboratory of Immunology and Molecular Biology, University Hospital, Universidade Federal de Sergipe, Aracaju, Brazil.

Published Erratum

Mariana do Rosário Souza et al. Front Pharmacol. 2022.

. 2022 Sep 6:13:999301.

doi: 10.3389/fphar.2022.999301. eCollection 2022.

¹ Health Science Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil.
² Parasitic Biology Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Brazil.
³ Tropical Medicine Graduate Program, Universidade Federal de Pernambuco, Recife, Brazil.
⁴ Department of Medicine, Universidade Federal de Sergipe, Aracaju, Brazil.
⁵ Department of Health Education, Universidade Federal de Sergipe, Lagarto, Brasil.
⁶ Department of Nursing, Universidade Federal de Sergipe, Lagarto, Brasil.
⁷ Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.
⁸ College of Pharmaceutical Sciences, Federal University of Vale do São Francisco (UNIVASF), Petrolina, Brazil.
⁹ Department of Medicine, Universidade Federal de Alagoas, Arapiraca, Brazil.
¹⁰ Department of Morphology, Universidade Federal de Sergipe, São Cristóvão, Brazil.
¹¹ Laboratory of Immunology and Molecular Biology, University Hospital, Universidade Federal de Sergipe, Aracaju, Brazil.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.891711.].

Keywords: COVID-19; COVID-19 pandemic; end TB strategy; global health; tuberculosis.

Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?
Souza MDR, da Paz WS, Sales VBDS, de Jesus GFH, Tavares DDS, Lima SVMA, Sousa ÁFL, de Melo EV, do Carmo RF, de Souza CDF, Bezerra-Santos M. Souza MDR, et al. Front Pharmacol. 2022 Jun 29;13:891711. doi: 10.3389/fphar.2022.891711. eCollection 2022. Front Pharmacol. 2022. PMID: 35847020 Free PMC article.